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PART I 
THE METABOLISM OF GLUTAR.IC ACID-3-C1 ~ IN INTACT RATS 
PART I 
CHAPTER I 
INTRODUCTION 
In nature glutaric acid is known to occur in sugar beets (1), 
sugar diffusion juice (2), wood distillation products (3), urine (4), 
tobacco smoke (5), plants (6, 7), coal (8) and ale (9). 
The interest in glutaric acid metabolism started in 1907 when 
Baer and Blum (10) presented evidence to the effect that the sub-
cutaneous injection of glutaric acid greatly reduces the amount of 
sugar and nitrogen in ~he urine, and also greatly diminishes or causes 
the disappearance of urinary acetone and acetoacetic acid in phlorhizin 
glycosuria. This conclusion however was contradicted by Ringer (11) 
who showed that glutaric acid has no inhibitory effect on the action 
of phlorhizin, that it does not reduce the sugar or nitrogen elimi na-
tion in phlorhizin glycosuria, and that it does not diminis h the acetone 
bodies in the urine. A year later Ringer (12 ) postulated the conversion 
of lysine to glutaric acid on the basis of the observation that neither 
lysine nor glutaric acid is glucogenic, a suggestion that was confirmed 
thirty years later by Neuberger and Sanger (13 ). 
On incubating guinea pig liver homogenates with a -aminoadipic 
acid-6-C14, Borsook et al. (14) in 1948 isolated radioactive a-keto-
glutaric acid and glutaric acid. This was followed by an extensive 
1 
• 
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research on lysine metabolism. Studies on the metabolism of labeled 
lysine in homogenates of guinea pig liver, in dogs (1 5 ) and in ra~s (16, 
17) since then, have provided evidence for the present pathway of lysine 
breakdown to glutaric acid. 
In 1959, Gholson et al. (18) showed glutaric acid to be a product 
of tryptophan metabolism by isolating radioactive urinary glutaric acid 
after metabolite overloading experiments using DL-tryptophan-7a-C14 or 
,-hydroxyanthranilic acid-H3 with glutaric acid. 
Besides its formation from lysine and tryptophan, glutaric acid is 
formed during the fermentation of L-xylose by Aspergillus niger (19 ). 
The initial work on glutaric acid metabolism in humans was done 
by Weitzel ( 20 ) who showed that glutaric acid did not appear in the 
urine after its administration, and thus concluded that it is metabolized. 
This investigation was followed by the studies of Rothstein and Miller 
(21) who concluded on the basis of the labeling patterns in urinary 
acetate, acetoacetate and glucose after the administration of glutaric 
acid-l, 5-C14 to normal and phlorhizinized rats, that decarboxylati on to 
butyrate or oxidation to ~-ketoglutarate followed by decarboxylati.on to 
acetoacetate were the most likely routes of catabolism of glutaric acid 
in the rat. Subsequently, on the basis of metabolite overloading experi-
ments, the same authors suggested tha t a -ketoglutarate and acetate were 
the products of glutarate catabolism (16 ). Miller and Bale ( 22 ), fol-
lowing the administration of lysine- 6-c14 to dogs, obtained from liver 
and plasma proteins glutamic acid having 71 per cent of the activity 
in the y-carboxyl and 25 per cent in the a -carboxyl . This again sug-
gested to them that the carbon chain of glutarate was converted , in 
part, to that of a-ketoglutarate. 
Thus, from the above-mentioned studies of Rothstein, Miller, and 
Bale (16, 17, 21, 22 ), two pathways were suggested for the metabolism 
3 
of glutaric acid. One of these involved direct conversion of the carbon 
chain of glutarate to that of a-ketoglutarate; the other involved the 
formation of acetate. In an effort to assess the relative importance 
of each pathway, Hobbs and Koeppe ( 23 ) studied the metabolism of glutaric 
acid-3-c14 in intact rats and found that the labeling patterns found in 
isolated glutamic acid, aspartic acid, and alanine were not compatible 
with a conversion to the carbon chain of a-ketoglutarate and indicated 
that glutarate was metabolized primarily via acetate. A reasonable 
hypothesis for the conversion to acetate would be (21, 23): glutarate 
glutaconate ~-hydroxyglutarate acetone-
dicarboxylate. In this manner glutaric acid-3-c14 would yield acetone-
dicarboxylic acid labeled in the carbonyl position. Subsequent decar-
boxylation to acetoacetate followed by cleavage to acetate would acc ount 
for the formation of carboxyl labeled aceta te. Als o it has been sug-
gested by others ( 24, 25 ) that acetoa ce t a te mi ght be f ormed from gl utarate 
via ethylma lonate . 
The objective of this i nves t igat i on was t o further e l ucidate t he 
metabolism of glutaric a cid in r ats by acquiring s ome i n f or ma tion abou t 
the nature of the intermediates in the oxidati on of gl u t a r ic a cid-3-c14 
to acetate. The approach was to study the metabol i sm of gluta r ic 
acid- 3-c14 in the rat by using the "me tabolite overloading" technique 
(16, 17). This method cons i sts of administering a labe led substance 
(glutaric acid- 3-c14 ) by intraperitoneal injection, t ogether wi th a 
large dos e o f sus pect ed me taboli t e . "The a s sumpti on that the i nj ect ed 
compound is equilibrated in some manner with simila r biologically f ormed 
4 
material is borne out by the finding that large doses of some non-
radioactive metabolites, after being partly excreted in the urine, were 
found to be radioactive. It is therefore reasonable to assume that some 
"sampling" of the biologically formed material does take place. It is 
possible that some compounds do not equilibrate well, and hence negative 
results are not necessarily significant"(l6). 
When metabolite overloading experiments using glutaric acid-3-c14 
and acetonedicarboxylate, ~-hydroxyglutarate or ethylmalonate were con-
ducted, urinary acetonedicarboxylat e, ~-hydroxyglutarat e and ethyl-
malonate did not contain significant radioactivity. On the other hand, 
overloading with acetoacetate resulted in the formation of urinary 
acetoacetate labeled chiefly in the carbonyl carbon. These results 
indicate that glutarate is converted to acetate via acetoacetate. 
CHAPTER II 
EXPERIMENTAL 
A. Synthesis of Compounds Used 
Glutaric acid-3-c14 was synthesized by Dr. s. P. Bagchi from para-
formaldehyde-C14 and diethylmalonate according to the method of Hobbs 
and Koeppe (23). The synthesis is summarized in Figure 1. The two 
preparations used had specific activities of 330 and 368 µc per millimole. 
Acetonedicarboxylic acid was prepared from citric acid according to 
the method of Adams et al. (26), and recrystallized from ethyl acetate. 
Since efficient cooling was required during both the addition of citric 
acid to fuming sulfuric acid and before final filtration of the acetone-
dicarboxylic acid, the reaction was run at about -12° C during the five 
hours of synthesis. Better yields were obtained when this low a tempera-
ture was maintained. 
~-Hydroxyglutaric acid was prepared by Dr. R. E. Koeppe in 70 per 
cent yield by the reduction of acetonedicarboxylic acid (sodium-salt) 
in aqueous solution with two moles of sodium borohydride (27). A more 
detailed description of this synthesis of ~-hydroxyglutaric acid has 
been published (28). 
Sodium acetoacetate was prepared by hydrolysis of acetoacetic 
ester at room temperature with 0.5 N sodium hydroxide according to the 
method of Ceresol ( 29 ). After hydrolysis the solution was lyophylized 
to remove ethanol. 
5 
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Figure 1. Synthesi s of Glutaric Acid- 3-c14 
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Ethylmalonic acid was prepared by Dr. R. E. Koeppe according to 
the method of Weiner (30). 
B. Animal Experiments 
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In each of the experiments performed, young male albino rats were 
used. The labeled glutaric acid and the compound used to overload were 
dissolved in 1 to 2 ml. of water. These solutions were administered by 
intraperitoneal injection after adjusting the pH to 7 to 8. Both the 
sodium acetoacetate solutions and the acetonedicarboxylic acid solutions 
were cooled in an ice bath before neutralization to pH 7 to 8. 
After injection, the animals were placed in an all-glass metabolism 
cage which was swept with air. Purina dog checkers and water were sup-
plied ad libitum throughout the experiments which varied in length from 
9 to 53 hours. Table I summarizes the data from the individual experi-
ments. 
The expired carbon dioxide was trapped in two gas washing bottles 
containing respectively 250 ml. and 100 ml. of 2 N sodium hydroxide. 
The contents of both bottles were mixed and made up to 500 ml. wit h 
carbon dioxide-free water and 2 ml. a l iquots were used f or c14 a ssay 
according to the method of Anthony and Long (31). 
The urine was collected in a s s parate flask attached t o the 
urinofecal separator at the bottom of the metabolism chamber. During 
the collection period, the urines from Rats 127 , 131, 139 and 140 were 
frozen to prevent the decomposition of the urinary acetonedicarboxylic 
and acetoacetic acids. 
Rats 127 and 131 received glutarate- 3-c14 and 2 . 5 t o 2. 6 millimol es 
of sodium acetonedicarboxylate by i ntraperitoneal i nj ecti on. I n t he 
case of Rat 127 the two were administered simultaneously, while Rat 131 
Rat 
No. 
127 
131 
133 
141 
139 
140 
143 
Weight 
in gm. 
280 
370 
320 
253 
170 
123 
326 
Catabolite 
acid admin-
istered 
Acetonedi -
carboxylate 
Acetonedi-
carboxylate 
t3-Hydroxy-
glutarate 
t3-Hydroxy-
glutarate 
Acetoacetate 
Acetrrncetate 
Etb.ylmalonat e 
TABLE I 
SUMMARY OF EXPERIMENTS PERFORMED 
Amount 
catabolite 
injected 
(mmoles) 
a 2.5 
2.6a 
b 2.5 
2.ob 
2.0 
2.0 
2.5 
Glutaric 
acid-3-C14 
given (µc) 
23.6 
ll.O 
12.8b 
ll.8b 
4.7 
12.8 
9.44 
Exhaled 
c1"02 
per cent 
of injected 
dose 
7.9 
~ 
56 
47 
58 
42 
50. 7 
aThe glutaric aci d-3-C14 was g:tven 15 minutes before the acetonedicarboxylic acid. 
bGi ven in two doses , 3. 5 ho,Jrs apart. 
" "This animal died of suffocation. The exact t i me of death is not known. 
Duration of 
experiment 
(hours) 
43 
9c 
53 
25 
13 
13 
24 
CXl 
9 
received the glutarate- 3-C14 15 minutes before the acetonedicarboxylate. 
The urine was frozen during the collection period. Acetonedicarboxylic 
acid was isolated from the urine of both rats, all steps being conducted 
in the cold room. The urine collected at the end of each experiment 
was filtered and diluted to a volume of 30 ml. An aliquot ( O.l ml.) of 
this was used for c14 analysis. The diluted urine was passed through 
a 2.5 x 17 cm. column of Amberlite IR-120 (H+ form). The effluent and 
washings were combined and lyophylized to dryness. The residue was 
chromatographed on a Celite column as described below. The acetone-
dicarboxylic acid peak came shortly after that of glutaric a cid as i s 
shown in Figure 2. 
Rats 133 and 141 received by intraperitoneal injection, glutarate-
-3-c14 and 2 to 2.5 millimoles of s odi um ~-hydroxyglut arate in t wo equal 
doses, 3. 5 hours apart. The urine collected a t the end of each experi-
ment was filtered and diluted to a volume of 25 ml. An aliquot ( O.l ml.) 
of this was used for C14 analysis. The urine was pa s s ed over a 2. 5 x 
+ 17 cm. Amberlite IR-120 (H form) column and the effluent and washings 
concentrated t o drynes s under vacuum. The res idue was f r actionated over 
Celite as descri bed be l ow. ~-Hydroxygl utar ic acid i s eluted slowly f r om 
Celite, t he . peak coming cons iderably after t hat of malonic acid as is 
shown in Figure 2. 
Rats 139 and 140 wer e f asted for 48 hours prior to the i ntraperitoneal 
administration of glutarate-3- c14 and about 2 mi l l i moles of sodi um- aceto-
acetate. The urines wer e collected ( f r ozen ) and t r eated as des cribed 
under degradat ion procedures . 
Rat 143 r eceived by intr aperitoneal injection, glutare te-3-C24 and 
2 . 5 millimoles of e thylma lonic acid. The uri ne collected over the per iod 
10 
of 24 hours was filtered and diluted to 25 ml. An aliquot ( 0.1 ml.) 
was used for C14 analysis. The remaining volume was passed over a 
2.5 x 17 cm. Amberlite IR-120 (H+ f orm) column and the effluent and 
washings concentrated to dryness under vacuum. The residue was acidified 
with 3 drops of 25 per cent sulfuric acid and fractionated over Celite 
as described below. 
C. Chromatographic Procedures 
1. Column Partition Chromatography 
The technique of Phares et al . ( 32 ) was empl oyed for t he puri -
fication of the organic acids used; namely, a ce tic , ace t oaceti c , glu t ar i c, 
acetonedicarboxylic, ~-hydroxyglutari c , ethylmalonic and but yric acids. 
Chromatographic columns (0.9 x 30 cm.) were packed with Celite by the 
addition of a slurry containing 5 gm. of Celite (which bad previously 
been thoroughly mixed with 3 ml. of 0.5 N sulfuri c acid) sus pended in 
a 10 per cent solution of acetone inn-hexane. A 3 t o 5 cm. layer of 
anhydrous sodium sulfate was packed on top of the Celite column. Prior 
to use the column was washed with 50 ml . of chlor oform satur a t ed with 
0. 5 N sulfuric acid. 
Each residue (approximately 2- 3 ml.) containi ng one of the 
above-mentioned organic acids obtained as descr i bed under the di ff er ent 
isolation procedures, was trans f erred quanti t ative l y through a long 
capillary tube to the top of t he Celi t e and tamped down. The flow r ate 
during elution was about 1 ml. per minute. Fr actions we r e collected 
with the aid of an automatic fr action co l lector and wer e t it r ated with 
0.1 N sodium hydroxide. Sui table corrections were made for the blank 
titrations (0.001 ml. of O.l N NaOH per 5 ml. of eff l uent) . Phenol r ed 
was used as indi cator. Figure 2 s hows a composi te diagram of the position 
0 
C\I 
I 
llQ 
u 
0 
~ 
~ 
u 
0 
C\I 
-4-
I 
~ 
a,.Hydroxy-
glutaric Acid 
Ethylmalonic 
Acid 
Glutaric 
Acid 
Acetic Acid 
Butyric Acid 
3. 0 2 . 0 l. O 
ml. 0.10 NaOH/ml. Effluent 
90 
80 
70 
...... 
• ~ 
a 
60~ 
~ 
1:/l 
z 
0 e 
50=! 
~ 
= 
40 
~ 
I 
30 
20 
10 
Figure 2. Celite Column Chromatography (Composite Diagram). 
11 
of the different acids on a standard chloroform-butanol chromatogram 
with a column 0.9 by 30 cm. Elution began with 1 per cent butanol in 
chloroform {CB-1) and continued with increasing amounts of butanol in 
chloroform as indicated (Figure 2). 
2. Paper Partition Chromatography 
12 
Aliquots of the eluates from the different chromatographic 
columns used, as well as of the various diluted animal urines were 
chromatographed separately on Whatman No. 1 paper in a n-butanol-acetic-
acid-water (9-1-2.5) system, using the ascending technique. After 
development, each chromatogram was steamed to vaporize adsorbed acetic 
acid and' dried under an infrared lamp. The dried chromatograms were 
sprayed with bromcresol green solution (100 mg. of bromcresol green per 
250 ml. of water) and dried. Table II shows the Rf's of the different 
acids tested by this method. 
D. Degradation Procedures 
1. Degradation of Acetonedi carboxylic Acid 
The acetonedicarboxylic acid peak obta ined as des cribed above 
was lyophilyzed to dryness. The dried materi a l was dissolved i n 2 ml. 
of water, acidified with 2 drops of 25 per cent sulfuric a cid, and 
heated in the Schmidt apparatus (Figure 3 ). Evolved carbon dioxide 
was trapped in 5 ml. of carbon dioxide-free 1 N sod i um hydroxide, and 
the liberated acetone was trapped in 5 ml. of ice- cold disti lled wat er. 
Figure 4 outlines the whole degradation procedure. 
TABLE II 
Rf VALUES OBTAINED WITH n-BUTANOL-
ACETIC ACID-WATER (9-1-2.5) 
Ethylmalonic Acid 0.81 
Glutaconic Acid 0.75 
Glutaric Acid 0.75 
Acetonedicarboxylic Acid 0.62 
a-Hydroxyglutaric Acid 0.52 
~-Hydroxyglutaric Acid 0.52 
Citric Acid o.42 
Sulfuric Acid 0.27 
13 
14 
Figure 3. The Schmidt Apparatus 
HOOC-CH2COCH2-COOH 
5 4 3 2 1 
Acid and Heat Treatment 
CH3COCH3 2C02 
4 3 2 1 
Acetone DNP 
CH3l 
2 
+ 
4 
+ 
5 
Figure 4. Degradation of Acetonedicarboxylic Acid 
To half of the aqueous acetone solution was added dropwise 
15 
2,4-dinitrophenylhydrazine reagent (3 gm. of 2,4-dinitrophenylhydrazine 
in 15 ml. of concentrated sulfuric acid). This solution was then added, 
with stirring, to 20 ml. of water and 70 ml. of 95 per cent ethanol. 
The phenylhydrazone precipitate was recrystallized from 3 ml. of 67 per 
cent hot ethanol. The melting point of the crystals after the second 
crystallization was 126°. 
To the other half of the aqueous acetone solution was added 
10 N sodium hydroxide (o.8 ml.) and then iodoform reagent (potassium 
iodide 20 gm., iodine 10 gm., in 80 ml. water) dropwise until no more 
iodoform precipitated. The iodoform (carbons 2 and 4 of acetonedi-
carboxylic acid) was removed by filtration and crystallized from hot 
75 per cent ethanol. The melting point of the crystals after the second 
crystallization was 119°. 
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The iodoform supernatant obtained above was dried over a hot 
plate, acidified with 5 ml. of 25 per cent sulfuric acid and steam 
distilled. The volatile acetic acid and excess iodine were collected 
in 250 ml. of distillate and acetate was extracted with ether. To the 
ether extract was added 8 ml. of 10 N sodium hydroxide and ether was 
removed by a jet of air. The dried material was dissolved in 2 ml. of 
water, transferred quantitatively to a pear-shaped flask and dried over-
night at 110° • 
Schmidt Reaction on Sodium Acetate (33) 
The dried material in the flask was chilled in an ice bath and 
o.6 ml. of 100 per cent sulfuric acid was added for each millimole of 
sodium acetate. The glass-stoppered flask was heated briefly over a 
small flame to dissolve the sodium acetate and then chilled in an ice 
bath. For each millimole of acetate, 100 mg. of sodium azide was added 
in one portion and the flask was attached to the Schmidt apparatus 
(Figure 3). The air inlet to the reaction flask was kept closed while 
the temperature of the water bath was raised to 70° over a period of 
one hour. The air inlet was then opened and carbon dioxide-free air 
was allowed to sweep slowly through the system for one hour while 
heating at 70° or above. The sodium hydroxide solution in the carbon 
dioxide trap was then transferred to a combustion tube for the deter-
mination of carbon dioxide and radioactivity. 
2. Degradation of ~-Hydroxyglutaric Acid 
The ~-hydroxyglutaric acid peak obtained as described above 
was dried on a rotary evaporator, acidified and run over another Celite 
column for further purification. One-fourth of this purified peak was 
transferred to a combustion tube, dried in an oven at 90°, and the 
17 
residue assayed for C14• To the rest (o.8 millimoles) of the ~-hydroxy-
glutaric acid peak was added 65 ml. of distilled water, 10 ml. of 50 per 
cent sulfuric acid and 35 ml. of 10 per cent mercuric sulfate (34). The 
mixture was heated to boiling, treated with 8 ml. of 5 per cent potassium 
dichromate solution, and heated under reflux for 90 minutes. This pro-
cedure converted the middle three carbons of ~-hydroxyglutaric acid to 
the mercury complex of acetone (34). At the end of the refluxing period 
the solution was cooled to room temperature and the yellowish-orange 
precipitate was removed by filtration and dried at 110° for one hour. 
The dried mercury-acetone complex was placed in 8 ml. of 2 N hydrochloric 
acid in a pear-shaped flask. This was attached to a Schmidt apparatus 
(Figure 3) and heated gently to boiling. The liberated acetone was 
trapped in 8 ml. of ice-cold distilled water. The phenylhydrazone 
derivative and iodoform were prepared and assayed as described above. 
3. Degradation of Acetoacetate 
Acetoacetic acid was decomposed into carbon dioxide and acetone 
(Figure 5) by the method of Van Slyke (34). This method was used for 
urinary acetoacetate in the metabolic overload experiment. 
+ 
4 
CH3COCH2COOH 
413 2 1 
Acid Treatment 
I 
Figure 5. Degradation of Acetoacetic Acid 
The urine, collected over a 13-hour period in a flask cooled 
in a dry ice-acetone mixture, was filtered and diluted to a volume of 
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25 ml. An aliquot (0.1 ml.) was removed for C14 analysis. The remaining 
urine was transferred to a 250 ml. volumetric flask containing 50 ml. 
of 20 per cent copper sulfate solution. Immediately a 10 per cent cal-
cium hydroxide suspension (approximately 50 ml.) was added until the 
solution was alkaline (pH 8 to 9). After standing at room temperature 
for one hour and at 5° for two hours, the mixture was filtered. The 
filtrate was cooled to 3° in an ice bath, adjusted to pH 2 and aerated 
for 20 minutes with carbon dioxide-free air to remove any dissolved 
carbon dioxide. After the addition of 10 ml. of 10 per cent mercuric 
sulfate the solution was heated under a reflux for one hour while the 
aeration was continued. The liberated carbon dioxide (from carbon 1 
of acetoacetate) was trapped in 1 N sodium hydroxide (5 ml.). The 
acetone-mercury complex was removed by filtration, washed with 100 ml. 
of water and dried at 110° for one hour. This was converted to acetone 
as described above. 
4. Degradation of Ethylmalonic Acid 
The ethylmalonic acid peak (Figure 2) obtained as des cribed 
above was pooled. An aliquot (0.1 millimole) was transferred to a 
combustion tube for C14 analysis. The rest of the peak was transferred 
to a pear-shaped flask and dried at 110°. The flask was placed in an 
ice bath and its contents acidified to pH 1 with 25 per cent sulfuric 
acid. Then the flask was attached to the Schmidt apparatus (Figure 3) 
and heated in a mineral oil bath to 180°. The liberated carbon dioxide 
was trapped in 1 N sodium hydroxide (5 ml.) and the butyric acid was 
trapped in ice-cold acidified water (5.0 ml.). The butyric acid was 
purified by Celite chromatography. The liberated carbon dioxide and 
purified butyric acid were assayed for radioactivity. 
E. Radioactivity Determinations 
Carbon analyses and ci4 assays involved manometric measurement of 
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CO2 (35) and determination of radioactivity with a vibrating . reed lel~ctr9ffleter 
(36). 
CHAPTER III 
RESULTS AND DISCUSSION 
A. Oxidation _2! Glutaric Acid-j-C14 
The experimental data are presented in Tables I, III and IV. 
The extent of the oxidation of glutaric acid-3-c14, as measured by 
C14o2 production, is shown in Table IV. It is apparent from Table IV 
that acetonedicarboxylic acid and ~-hydroxyglutaric acid inhibit glutaric 
acid oxidation. In Rat 128, Table III, a dose of acetonedicarboxylic acid, 
slightly greater than that given Rats 127 and 131, diminished the c14o2 
excretion virtually to zero, while the untreated Rat 129 converted 71 per 
cent of a dose of glutaric acid-3-c14 to C14o2 in two hours. As a result 
of this observation, Rat 131 was given glutaric acid-3-C14 fifteen minutes 
before acetonedicarboxylic acid to assure the presence of labeled metabo-
lites; and subsequently acetonedicarboxylic acid toxicity studies were run 
as shown in Table III. These studies show that acetonedicarboxylic acid, 
in doses of one milligram per gram body weight, does not greatly depress 
the oxidation by rats of acetate-l-C14 , alanine-l-C14 , or glutamic ac id-
The release of C14o2 from glutaric acid-3-c14 by intact rats has 
already been reported by Hobbs and Koeppe (23). Oxidation of glutaric acid-
-l,5-c14 by liver mitochondria has been reported by Rothstein and Greenberg 
(37), and by Bagchi et al. (28). 
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TABLE III 
ACETONEDICARBOXYLIC ACID TOXICITY EXPERIMENTS 
Rat No. Rat Milligram Labeled µc Per cent Duration 
weight acetone- acid acid c1402 of 
dicarboxylic administered administered exhaled experiment 
administered (hrs) 
-
128 390 453 Glutaric acid- 13.5 0 42 
3-c14 
129 385 None Glutaric acid- 2.36 81.3 23 
3-c14 
136 (i) 420 347 DL-Alanine- 15. 2 73.5 18 
i-ci4 
(ii) None DL-Alanine-
1-ci4 
14.35 124 25 1/2 
142 (i) 245 None Sodium acetate- 13.26 57 24 
2-c14 
(ii) 245 Sodium acetate- 13.26 67.8 24 
2-c14 
(iii) None Glutamic acid- 7.0 49 24 
HCL-5-C14 
(iv) 247 Glutamic acid- 7.0 42 24 
HC1-5-C14 
(v) 254 Glutaric acid-
3-c1.4 
9.44 44 21 1/2 
I\) 
I-' 
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Table IV shows that the administration of acetonedicarboxylic acid 
or ~-hydroxyglutaric acid with glutaric acid-3-c14 facilitated a more 
rapid urinary excretion of C14• Whereas Rat 129 (Table III), given labeled 
glutaric acid alone, excreted less than 10 per cent of the dose in the 
urine in 24 hours, the treated rats excreted from 18.6 to 32.2 per cent of 
the dose as shown in Table IV. In the case of Rat 127, most of the urinary 
c14 was located in the glutaric acid peak. 
B. Labeling in Acetonedicarboxylic Acid, ~-Hydroxyglutaric Acid, and 
Ethylmalonic Acid 
As shown in Table IV, all efforts to demonstrate the formation in vivo 
of acetonedicarboxylic acid, ~-hydroxyglutaric acid, or ethylmalonic acid 
from glutaric acid-3-c14 failed. Although the ~-hydroxyglutaric acid 
peaks (Figure 2) obtained from the urine had small amounts of activity, 
the acetone prepared from one of these peaks had negligible activity. 
Thus, these results supported by similar studies in vitro (28) do not 
agree with the postulate (21, 23) that these acids are intermediates in 
glutaric acid catabolism. However, the failure of glutaric acid-3-C14 to 
label acetonedicarboxylic acid, ~-hydroxyglutaric acid or ethylmalonic 
acid does not disprove the previous postulates (21, 23), since exogenous 
acid may not equilibrate with that formed endogenously ( 38, 39, 40 ). 
C. Labeling in Acetoacetic Acid 
As shown in Table IV, glutaric acid- 3-C14 was converted in vivo to 
acetoacetic acid containing c14 only in the carboxyl and carbonyl carbons. 
The ratio of carbonyl to carboxyl radioactivity was greater than 3 in 
both experiments. These results were supported by studies in vitro (28). 
Similar results have been reported by Crandall et al. (41) who f ound that 
octanoic acid-7-C14 gave rise in vitro to acetoacetate in which the carbonyl 
Rat 
No. 
127 
131 
133 
141 
139 
140 
143 
TABLE IV 
DA'EA OBTAINED FROM RATS GIVEII GLUTAIUC ACIJ>-}--C14 AND SUSPECTED CAIABOLITES 
Rat 
weight 
g 
28o 
370 
320 
253 
170 
123 
326 
Catabolite acid 
administered 
Acetonedicarboxylic 
Acetonedicarboxylic 
tl-Bydroxyglutaric 
tl-Bydroxyglutaric 
Acetoacetic 
Acetoacetic 
Ethylmalonic 
I Amount I Glutaric I Injection I Dura- I Total I 
administered acid- exhaled tion radio-
3-c14 as CO2 of activity 
given experi-
ment 
-,le µc 1, bra µc 
2.5 23.6 7.9 43 4.4 
2.6b llb 36 9c 2.2 
2.5d 12.8d 56 53 2.8 
2d 11.8d 47 25 3.8 
2 4. 7 58 13 0.9 
2 12.8 42 13 2.3 
2.5 9.4 50.8 24 o. 7 
8too low for accurate measurement. These samples may have had no radioactivity. 
bThe glutaric acid-3-~• was given 15 minutes before the acetonedicarboxylic acid. 
°This animal died of suffocation. The exact time of death is not known. 
dGiven in 2 doses, 3. 5 hours apart. 
Total I t,-Bydroxy-
catabolite glutarate 
isolated peak 
-,le 
0.5 
0.9 
1.2 I 9 1.2 24.6 
o. 36.( o. 28). 
o.49(0.05)• 
o.82 
~igures are based on CO2 release; those in parentheses are baaed on recovery of the mer cury- acetone complex. 
f Purified once on a Celite column. 
..  
Urine excretion data 
Acetone 
from 
catabolite 
0 
0 
0.3a 
697 
1740 
Acetate 
from 
acetone 
Car-
boxyl 
of 
acetate 
froa 
acetoae 
...,c/--,le 
2.2a 
483 
1355 
lodoform 
from 
acetone 
0.5 
0 
Car- I 
boxyl 
fron , 
acet o .~ I 
acetate _l 
135 
111 
Butyrate 
from 
ethyl-
malonatef 
0. 5 
l\.) 
w 
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CHAPTER IV 
SUMMARY 
When male rats were given glutaric acid-3-c14 and either acetone-
dicarboxylic acid, ~-hydroxyglutaric acid, ethylmalonic acid, or aceto-
acetic acid, urine analysis gave the following results: 
1. The three middle carbons of acetonedicarboxylic acid and~-
hydroxyglutaric acids contained no detectable C14• 
2. The butyric acid obtained from the decarboxylation of ethyl-
malonic acid contained no significant radioactivity, 
3. Acetoacetic acid was labeled in the carbonyl and carboxyl 
carbons, the carbonyl to carboxyl ratio being at least 3:l. 
These results indicate that glutarate is converted to acetate via 
acetoacetate. However, no insight was gained concerning the intermediates 
in this conversion. 
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PART II 
THE METABOLISM OF a,y-DIAMINOBUTYRIC ACID-2-C1 ~ IN INTACT RATS 
PART II 
CHAPTER I 
INTRODUCTION 
In 1947 two groups of investigators reported almost simultaneously 
the isolation of a new antibiotic polypeptide from Bacillus polymyxa 
( 1 , 2 ) and called it polymyxin. A month later, a third group ( 3 ) re-
ported the isolation of the antibiotic aerosporin from Bacillus aerosporus. 
Further investigation ( 4) has shown that the two species, Bacillus polymyxa 
and Bacillus aerosporus, are identical. Other strains have been found to 
elaborate related antibiotics, and these are known collectively as poly-
myxins. At present, a total of five polymyxins are known ( 4 ) and are 
designated polymyxin A, B, c, D and E. Circulin (5), isolated from Bacillus 
circulans, and polypeptin ( 6 , 7 ) , isolated from Bacillus kremieniewski, 
also appear to belong to the polymyxin category. 
The polymyxins differ somewhat in-'pharmacological properties but are 
similar in having a narrow antibacterial spectrum that is limited to certain 
gram negative bacteria, including Hemophilis influenza, Brucella abortus, 
Salmonella enteritidis, Escherichia coli, and Proteus vulgaris ( 2 ) • 
The early clinical use of polymyxin D (ca 1950) was subsequently 
abandoned due to its production of some undesirable side-effects, especially 
kidney damage. Polymixin D ( 8 ), the form then employed clinically, was 
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found to contain D-serine and was somewhat more toxic than polymyxins B 
and E which do not contain this amino acid. Polymyxin Bis used mainly for 
topical application. It acts synergistically with a number of other anti-
biotics like bacitracin, an antibiotic which is effective against gram 
positive pathogens, 
The polymyxins are also related chemically. They are strongly basic, 
cyclic polypeptides, They all yield a, 1-diaminobutyric acid, threonine, 
and isopelargonic acid, a branched chain saturated, optically active fatty 
acid (6-methyl-octan-1-oic). Polypeptin is reported to contain an iso-
octanoic acid (7) rather than isopelargonic acid. Most of the diamino-
butyric acid residues in polymyxin have freer-amino groups (9, 10 ), 
The amino acid composition of the various members of the polymyxin complex 
have been determined (11) and are summarized in Table I. 
Studies on the structure of polymyxin B, conducted independently 
by Hausman and Craig (12) and by Biserte and Dautrevaux (lo), were in 
substantial agreement in suggesting a cyclic octapeptide in so far as 
no free a-amino groups were detectable, Hausman and Craig (13 ) have 
established that commercial polymyxin Bis itself a mixture of two com-
ponents, polymyxins Bi and B2 , Polymyxin Bi comprises about 65 per cent 
of the antibiotic and polymyxin B2 the remainder, When the same workers 
(13) subjected polymyxin B to partial acid hydrolysis they obtained a 
complicated mixture of strongly basic peptides. These were converted 
to their dinitrophenyl derivatives and were separated by counter current 
distribution, or were fractionated on Dowex 50 ion exchange resin (10). 
The identification of the dinitrophenyl derivatives showed that all of 
the free amino groups were the r-amino groups of the a, 1 -diaminobutyric 
acid residues. No dinitrophenyl derivatives of a -amino acids were found, 
TABLE I 
AMINO ACID COMPONENTS OF THE POLYMYXINS 
Polymyxin Type 
Amino Acid Components A B C D E Polypeptin Circulin 
Leucine D lL lD D 2L lD 
Phenylalanine lD L lD 
Threonine L 2L L 3L L lL lL 
Serine lD 
a,r-Diaminobutyric Acid L& 5L L 5L L 3L 5L 
DL 
Valine 1D 
Isoleucine lL 
The presence of one free carboxyl group was indicated by titration. 
These data suggested that polymyxin B1 is also a cyclic polypeptide. 
The two possible structures suggested by these studies (10, 13) are 
shown in Figure 1 and Figure 2. 
In addition to the polymyxins, colistin also contains a,y-diamino-
butyric acid. Colistin is an antibiotic peptide which contains five 
molecules of a,y-diaminobutyric acid and one molecule of each of the 
following: L-threonine, L-leucine, D-leucine, and isopelargonic acid 
(14). Recently, Namiki (15) described a new method for the production 
and purification of colistin. Also, he showed that the antibiotic has 
a remarkable inhibitory effect on Shigella dysenteria, Salmonella 
typhosa, Escherichia coli, and Pseudomonas aeruginosa. 
From this brief survey, it is apparent (Table I) that a,y-diamino-
butyric acid is an important component of several useful antibiotics. 
To our knowledge, prior to this study no investigations were conducted 
regarding the mammalian catabolism of a,y-diaminobutyric acid. The aim 
of this investigation was to study the gross metabolism of a,y-diamino-
butyric acid by rats. The approach used was to s ynthesize DL-, L-, and 
D-a,y-diaminobutyric acids- 2-C14 by the Schmidt r eaction (16 ) from DL-, 
L-, and D-glutamic acids-2-C14, and to study their metabolism in r ats. 
After administration to rats, the exhaled C14o2 , the excreted C14 in 
urine and the labeling patterns in carcass aspartate, glutamate and 
alanine (17) were d~termined. 
The results of this study showed (a) that the L- i somer of a, y-
-diaminobutyric acid is oxidized more rapidly that the D-isomer, (b) that 
the urine had a substantial amount of radioactivity, ( c ) that most of the 
radioactive components of the urine were probably free or conjugated 
DAB ( y-NH2) 
/ ~DAB (r-NHa) Leu 
i 
Phe 
i 
DAB 
' 
I 
DAB 
T 
Thr-OH 
l 
DAB ( y-NH2) 
i 
Ipel. 
Structures) (Possible 
Polymyxin B Figure 2. 
Figure 1. 
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a,7-diaminobutyric acids and (d) that the labeling patterns observed in 
isolated carcass glutamate, aspartate and alanine do not indicate an 
obvious route for the oxidation of these compounds. 
CHAPTER II 
EXPERIMENTAL 
A. Synthesis of g,z-Diaminobutyric Acid-~-c14 
DL-, L- and D-a,y-diaminobutyric acids-2-C14 have been synthesized by 
the Schmidt reaction (16) as modified by Koeppe and Hill (17), from DL-, 
L- and D-glutamic acids-2-C14• The D- and L-glutarnic acids-2-C14 were 
prepared by Dr. W. E. Wilson (18). 
In a pear-shaped flask were placed 0.14 millimole of glutamic acid-
2-C14 and 0.16 millimole of unlabeled glutamic acid. The flask was 
stoppered and cooled in an ice bath, and then o.40 ml. of 100 per cent 
sulfuric acid was added with shaking and warming, until the glutamic acid 
dissolved. The resulting sulfuric acid solution was chilled in an ice 
bath. Then 75 mg. of sodium azide were added with shaking to disperse 
the azide crystals. The flask was quickly attached to the apparatus shown 
in Figure 3, one trap of which contained an acid permanganate solution 
while the second trap contained 5 ml. of 1 N carbon dioxide-free sodium 
hydroxide. The reaction usually proceeded vigorously upon warming the 
reaction flask to 40° c. When the rapid gas evolution subsided, the water 
bath temperature was raised to 50° Cover a period of one hour and then 
kept at this temperature for one hour. The bath's temperature was finally 
raised to boiling over a period of half an hour, during which time the 
system was swept with carbon dioxide-free air. Then the reaction flask 
was removed and one drop of fuming sulfuric acid and 35 mg. of sodium 
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azide were added. The system was closed again and sweeping with carbon 
dioxide-free air continued for half an hour while the reaction flask was 
heated at 90° c. Evolved carbon dioxide, which was trapped in alkali, was 
assayed for radioactivity and found to contain less than 0.01 to 0.03 per 
cent of the total radioactivity of the glutamic acid used for synthesis. 
The contents of the flask were poured into a 150 ml. beaker and 
titrated to pH 6.0 (pH meter) with a hot saturated barium hydroxide solu-
tion. Precipitated barium sulfate was removed by centrifugation. The 
supernatant was adjusted to pH 3.0 with 2 N hydrochloric acid. The re-
sulting solution (90 ml.) was passed over a Dowex-1 column (OH- form; 
13 x 1.5 cm.). The column was washed with distilled water until the 
effluent reaction was neutral, then it was eluted with O.l N acetic acid 
solution until the acetate band was approximately 8 cm. deep. Frequent 
ninhydrin tests (all negative) were run on the eluate during this elua-
tion period. Then the Dowex-1 column was mounted over an Amberlite IR-
45 column (acetate form; 13 x 1.5 cm.). The columns were eluted with 
approximately 30 ml. O.l N acetic acid solution, 3.0 ml. fractions being 
collected on an automatic fraction collector. On cold runs this method 
was shown to effect the separation of a, 1-diaminobutyric acid from 
glutamic acid, the latter being eluted 6 to 10 fractions after the 
last fraction of a, 1-diaminobutyric acid. Fractions containing ninhydrin-
positive material were pooled in a beaker and the pH of this solution was 
adjusted to about 1 with 2 N hydrochloric acid solution. The beaker was 
then placed on a hot plate (70 to 80°), and its contents were evaporated 
to dryness by a jet of air. 
The material in the beaker was dissolved in approximately 1.5 ml. 
of distilled water. The pH was brought up to 3.5 to 3.8 with a few 
37 
drops of 25 per cent pyridine. After the solution had been cooled in 
the refrigerator for an hour, a,y-diaminobutyric acid monohydrochloride 
was crystallized by the addition of approximately 10 ml. of absolute 
ethanol. After standing in the deep freeze over night, the crystals 
were removed by filtration, washed with ethanol, acetone and anhydrous 
ether, and dried in a dessicator over phosphorous pentoxide. The yield 
of DL- and L-a,y-diaminobutyric acid-2-C14 monohydrochloride was ap-
proximately 70 per cent. A 50 per cent yield of the labeled D-isomer 
was obtained. 
Paper chromatography of the compound in an 80 per cent phenol-
water mixture containing 1 per cent ammonium hydroxide (19) gave a 
single ninhydrin spot with an Rf value of 0.74, identical to that of 
authentic a,y-dia.minobutyric acid. All of the radioactivity on the 
chromatogram was shown by the paper strip scanning technique to be 
... , __ 
located in the area occupied by the ninhydrin spot. 
The melting points of the synthesized DL-, and L-diaminobutyric 
acids-2-C14 ranged from 245 to 247° c, and that of D-diaminobutyric acid-
2-C14 was 237° C. The labeled D-isomer appeared to be less pure. 
B. Determination of the Purity of!!- and ~-Diaminobutyric Acids-~-C14 
The procedure for determini.ng the purit y of each isomer of a, y-
diaminobutyric a cid-2-C1 ~ was that of Minthorn and Koeppe (20). This 
procedure employs repeat ed crystallization t o a constant speci f ic 
activity of a mixture of enantiomorphs in which one (unlabeled) is 
present in a large excess of the other (labeled). These crystalliza-
tions would be expected to lead to a purificat ion of the more abundant 
isomer; hence, the presence of isotope in the purified abundant isomer 
would represent contamination of the labeled antipode. 
When the synthesized L-a,y-dia~inobutyric acid-2-ci4 was diluted 
about 500-fold with unlabeled D-a,y-diaminobutyric acid it was found that, 
after seven crystallizations, the picrate derivative of D-a,y-diamino-
butyric acid had a specific activity of 1.56 microcuries per millimole. 
This corresponds to a maximum contamination of l.6/96.6, or 1.7 per cent 
of the synthesized L-a,y-diaminobutyric acid-2-ci4 by D-a,y-diamino-
butyric acid-2-ci4 (Table II). 
When the synthesized D-a,y-diaminobutyric acid-2-ci~ was diluted 
about 300-fold with unlabeled L-a,y-diaminobutyric acid, the recrystal-
lized picrate derivative of L-a,y-diaminobutyric acid had a specific 
activity of 0.9 microcuries per millimole. This indicated that the 
greatest possible contamination of the synthesized D-a,y-diaminobutyric 
acid-2-C14 by L-a,y-diaminobutyric acid-2-C14 was 0.9/69.0, or 1.4 per cent. 
c. Animal Experiments.!!!£ Isolation of Amino Acids 
Intraperitoneal injections of the isomers of a,r-diaminobutyric 
acid-2-C14 and collection of exhaled C1402 and excreted urine were carried 
out as previously described under Part I, Chapter II. Table III surmnarizes 
the data from the individual experiments. 
After the rat was killed, "carcass" and liver protein powders were 
prepared (21). "Carcass" refers to the entire animal, except liver, 
including the washed gastroi ntestinal tract. 
The carcass protein from Rats 151 and 159 was hydrolyzed by boili ng 
under reflux for 24 hours with 10 volumes of 6 N hydrochloric acid. 
After repeated vacuum distil lation, the hydrolysates were treated with 
charcoal (Darco G-60 ) (22 ). 
The various amino acids were then fractionated and isolated by dis-
placement chromatographic techniques as described by Partridge and 
Brimley (23) as modified by Koeppe et al. ( 21). 
TABLE II 
SPECIFIC ACTIVITIES AFTER SUCCESSIVE RECRYSTALLIZATIONS OF L- AND 
D-a,,-DIAMINOBUTYRIC ACID-2-C14 DILUTED 300 TO 500-FOLD 
WITH CARRIER D- OR L-a,,-DIAMINOBUTYRIC ACID 
No. of 
recrystallization 
a,,-Diaminobutyric 
Acid-2-C14 
1 
2 
6 
7 
Picrate Derivative 
on 2 
1 
2 
3 
Picrate Derivative 
on 7 
L14 + D 
12.1 
1.6 
µc/nunole1 
L14 + L D14 + L 
95.7 
96.6 
93.2 
1.2 
D14 + D 
71.2 
66.8 
68.5 
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1 Corrected for dilution with carrier. Therefore the results gi ve 
the relative specific activities of each precipitate. 
TABLE Ill 
A SUMMARY OF THE EXPERIMENTAL DATA 
Rat Weight Compound Micro curies Per Cent 
No. in gm. administered injected niicrocuries 
exhaled 
151 135 DL-a,y-Diaminobutyric 11.4 15.3 
Acid-2-C14 
157 lo6 DL-a, y-Diaminobutyric 5.7 10.2 
Acid-2-C14 
159 A 157 L-a,y-Diaminobutyric 
Acid-2-C14 
2.6 27.7 
B 1571 L-a,y-Diaminobutyric 14.4 18.82 
Acid-2-C14 
1683 150 D-a,y-Diaminobutyric 0.536 6.7 
Acid-2-c14 
1 Administered 24 hours after first dose. 
2 Based on second injection administered. 
3 Female rat. 
Per Cent 
microcuries 
in urine 
48.2 
26.8 
18.9 
22.6 
46.3 
Duration 
of 
experiment 
(hrs) 
-
24 
24 
24 
24 
27 
+ 0 
41 
The isolated aspartic acid, glutamic acid and alanine were character-
ized by paper chromatography and ninhydrin-released CO2 • The chromatography 
was performed on paper impregnated with o.1 M phosphate buffer (pH 7) by 
using 76 per cent aqueous ethanol as the developing solvent. All the 
samples were recrystallized to constant specific activity with the ex-
ception of carcass alanine of Rat 151. 
D. Degradation Procedures 
The degradation of glutamic acid was carried out by the method of 
Mosbach et al. (24) as modified by Koeppe and Hill (21). 
The degradation of alanine was carried out as described by Koeppe, 
Minthorn and Hill (25). 
Aspartic acid was decarboxylated with ninhydrin (26). 
Carbon analyses and c1 • assays were accomplished by the use of 
procedures discussed in Part I, Chapter II. These involved manometric 
measurement of carbon dioxide and determination of radioactivity with 
a vibrating-reed electrometer. 
E. Characterization of Excretory Products in Urine 
The urine collected at the end of each experiment was filtered and 
diluted to a 25 ml. volume. An aliquot (o.l ml.) of this was used for 
c14 analyses. The diluted urine was passed through a Dowex-I column 
(OH- form, 20 x l.5 cm.). The column was washed with 250 ml. of distilled 
water. Both the effluent and the washings were combined and dried on a 
hot plate with the aid of a jet of air. The dried material was made up 
to a known volume and an aliquot of it was withdrawn and assayed for ci4 • 
The Dowex-I column was then eluted with approximately 200 ml. of 1 N 
acetic acid, and the eluate was lyophylized to dryness. The residue 
was dissolved in 25 ml. of water and an aliquot was assayed for C14• 
The remaining volume was passed over an Amberlite IRC-50 column 
(acetate form, pH 4.7; 25 x 1.0 cm.). The column was washed with 
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250 ml. of distilled water. Both the effluent and the washings were 
combined and dried. The dried material was dissolved in water and 
assayed for C14• The IRC-50 column was then eluted with approximately 
200 ml. of 0.2 N hydrochloric acid. The eluate was dried, made up to 
volume, and assayed for radioactivity. 
Aliquots from the different effluents and eluants obtained from 
the Dowex-I and the Amberlite IRC-50 columns were chromatogramed 
separately on Whatman No. 1 paper in an 80 per cent phenol-water mix-
ture containing 1 per cent ammonium hydroxide (19). After development, 
the chromatogram was dried, sprayed with 0.2 per cent ninhydrin and 
dried again. Strips from the chromatogram containing the ninhydrin-
positive spots were cut out and run on a paper strip scanning instrument 
to see whether all of the radioactivity on the chromatogram was located 
in an area identical with the ninhydrin spots. 
To two volumes (10 ml. each) of the Dowex-I eluant from the urine 
of Rat 151 were added separately 2 millimoles of L-a,y-diaminobutyric 
acid and 2 millimoles of D-a,y-diaminobutyric acid. Successive crystal-
lization; as well as picrate derivatives, were made as described 
under the determination of the purity of L- and D-a,y-diaminobutyric 
acids. 
CHAPTER III 
RESULTS AND DISCUSSION 
A. Gross Distribution of c14 
The gross distribution of C14 in the tissues and excretory products 
of these rats following intraperitoneal administration of DL-, L-, and 
D-a,y-diaminobutyric acid-2-C14 is shown in Table IV. Both isomers are 
oxidized to CO2 by rat tissue. The presence of large amounts of c14 
in urine suggests that the ability to oxidize a,y-diaminobutyric acid is 
limited. 
B. Excretion of C14o2 
A general summary of the experimental data is presented in Table 
III (page 40). Data relating to the rate of excretion of c14o2 may 
be found in Tables III and V. From Tables III and V it may be seen 
that the rate of excretion of c14o2 by rats receiving DL-a,y-diamino-
butyric acid-2-C14 is somewhat slower than the rate by rats receiving 
the L-isomer. If one considers that 50 per cent of the injected dose 
of DL-a,y-diaminobutyric acid-2-C14 is L-a,y-diaminobutyric a cid-2-C14 , 
then one might conclude that most of the exhaled radioactivity of the 
rats receiving DL-a,y-diaminobutyric acid-2-C14 is due to the oxidation 
of the L-isomer. On the basis of this assumption, D-a,y-diaminobutyric 
acid would be expected to be metabolized more slowly than its enantiomorph. 
The presence of only 7 per cent of the administered radioactivity in the 
exhaled CO2 of Rat 168 substanti ates this expectation. It should also be 
TABLE IV 
GROSS DISTRIBUTION1 OF C14 IN TISSUES AND EXCRETORY PRODUCTS 
OF RATS ADMINISTERED a,y-DIAMINOBUTYRIC ACIDS-2-c14 
Rat 1512 Rat 159 Rat 1683 
Rat weight g. 135 157 150 
Test dose mg. 5.2 27.2 1.2 
Administered µc 11.4 17.0 0.536 
Per Cent c14 Administered Dose 
Exhaled CO2 15.2 20.64 6.7 
Urine 48.2 22.44 46.3 
Carcass5 protein 1.2 1.5 
Liver protein 0.2 0.3 
Liver glycogen 0.2 0.3 
Total 65.0 44.9 53. 0 
1Twenty-four hours after the first administration of the isotope, 
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with the exception of Rat 159 which received two doses of L-a,y-diamino-
butyric acid-2-Cl.4 24 hours apart. 
2 Injected DL-a,y-diaminobutyric acid-2-Cl.4 • 
3 Injected D-a,y-diaminobutyric a cid-2-Cl.4 • 
4 Based on total dose injected. 
5 Refers to the entire animal, except liver, including the washed 
gastrointestinal tract. 
Rat 
No. 
151 
157 
159A 
l59B1 
168 
TABLE V 
EXHALATION OF c1402 AFTER INJECTION OF a,7-DIAMINOBUTYRIC 
ACID-2-C14 ISOMERS INTO RATS 
a,7-Diamino- A.l.nount The cumulative exhalation 
butyric acid-2-ci4 in of c1402 as per cent 
isomer administered µc of the injected dose 
First Second Twenty- four 
hour hour hour 
DL 11.4 o.4 3.3 15.3 
DL 5.7 o.4 1.3 10.2 
L 2.6 1.5 5.4 33.5 
L 14.4 o. 7 2.7 21.7 
D o. 5 0 0.2 7.0 
1 Given 24 hours after the administration of the first dose. 
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noted that a small dose of L-a,y-diaminobutyric acid-2-C14 is oxidized 
almost three times as rapidly as a larger dose. This observation is in 
agreement with the earlier postulate that the ability of rat tissue to 
oxidize a,y-diaminobutyric acid is rather limited. 
c. Distribution of C14 in Carcass Glutamate and Alanine After Adminis-
tration of DL- and ~-~,.r-Diaminobutyric Acid-g-c14 
The labeling patterns obtained in carcass glutamic acid and carcass 
alanine after injection of DL- 1 and L-o:,y-diaminobutyric acid-2-C14 are 
shown in Tables VI and VII. As may be observed, radioactivity is 
distributed throughout the entire molecule of both glutamate and alanine. 
Comparison of these labeling patterns with those given by known metabolic 
intermediates (17, 21) does not indicate an obvious route for the oxida-
tion of these compounds. 
D. Nature.£! the Urinary Excretion Products 
A preliminary study on the nature of the urinary excretion products 
in the urine of rats receiving the isomers of a,r-diaminobutyric acid-
2-C14, has been performed as described in Part II, Chapter II. 
Studies to date have shown that these compounds are either free 
a,y-diaminobutyric acids or conjugated a,y-diaminobutyric acids. Chromato-
grams obtained from the Amberlite IRC-50 eluants had a radioactive peak 
having an Rf identical to that of authentic a,y-diaminobutyric acid, 
namely 0.73 to 0.75. In another study, it has been found by employing 
the technique described on page 37 that the eluant from Dowex-I of Rat 
151 contains seven times as much D-a,y-diaminobutyric a cid-2-C14 as it 
does L-a,y-diaminobutyric acid-2-C14• This is compatable with the ob-
servation that the L-isomer is oxidized more rapidly than its enantiomorph. 
However, complete identification of the urinary excretion products will 
require further investigation. 
TABLE VI 
LABELING PATTERNS IN CAR.CASS GLUTAMIC ACID, ASPARTIC ACID, 
AND ALANINE AFTER ADMINISTRATION OF DL-a,r-
DIAMINOBUTYRIC-2-C14 
Rat 151 
mµ.c per 
per cent 
mm.ale total 
Glutamic acid 
Total 3 .. 01 
Carbon 1 1.23 40.9 
Aspartic acid 
Total 2.00 
Carbons 1 
and 4 0.92 46.o 
Alanine 
Total 2.13 
Carbon 1 0.62 29.1 
Carbon 2 o.84 39.4 
Carbon 3 0 .. 50 23.5 
Sum 1.96 92.0 
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TABLE VII 
LABELING PATTERNS IN CARCASS GLUTAMIC ACID, ASPARTIC ACID 
AND ALANINE AFTER ADMINISTRATION OF L..a,r-
DIAMINOBUTYRIC ACID-2-C14 
Rat 122 mµc per 
per cent 
mmole .total 
Glutamic acid 
Total 3.47 
Carbon 1 1.34 38.6 
Carbon 2 0.62 17.9 
Carbon 3 0.61 17.6 
Carbon 4 0.24 6.8 
Carbon 5 o.42 12.1 
Sum 3.23 93.0 
Aspartic acid 
Total 2.57 
Carbons 1 
and 4 1.62 63.0 
Alanine 
Total 1.94 
Carbon 1 o. 77 39. 7 
Carbon 2 0.65 35.5 
Carbon 3 0.24 14.4 
Sum 1.66 89.6 
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CHAPTER IV 
SUMMARY 
DL-, L-, and D-a,y-Diaminobutyric acids-2-C14 were synthesized by 
the Schmidt reaction from DL-, L-, and D-glutamic acids-2-C14• 
When these compounds were injected intraperitoneally into rats, 
radioactivity was found in the exhaled carbon dioxide, in the excreted 
urine, in the proteins, and in liver glycogen. Further analyses and 
degradations gave the following results: 
1. The L-isomer of a, y-diamino,butyric acid is oxidized more rapidly 
than the D-isomer, 
2. The excreted urine had a substantial amount of radioactivity. 
3. Most of the radioactive components of the urine were probably either 
free or conjugated a,y-diaminobutyric acids, 
4. The labeling patterns observed in isolated carcass glutamate, 
aspartate and alanine do not indicate an obvious route for the 
oxidation of these compounds. 
1. 
2. 
4. 
6. 
8. 
10. 
11. 
12. 
13. 
14. 
16. 
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